Read more
Offering an all-encompassing review, this vital reference aids early recognition and improved treatment of medication-induced movement disorders.
List of contents
List of contributors; Dedication; Introduction; 1. Acute akathisia Drew S. Kern and Anthony E. Lang; 2. Acute dystonia Anne Marthe Meppelink and Mark J. Edwards; 3. Neuroleptic malignant syndrome Atbin Djamashidian and Sean S. O'Sullivan; 4. Serotonin syndrome Dimitrios A. Nacopoulos and Hubert H. Fernandez; 5. Neuroleptic Parkinsonism Joseph H. Friedman; 6. Tardive syndromes Daniel Tarsy and Raminder Parihar; 7. Tardive dyskinesia treatment Tracy M. Jones, Israt Jahan and Theresa A. Zesiewicz; 8. Atypical antipsychotics and movement disorders Rob M. A. de Bie; 9. Restless legs syndrome Roongroj Bhidayasiri and Pattamon Panyakaew; 10. Medication-induced tremors Peter A. Lewitt; 11. L-Dopa dyskinesias Juan Ramirez-Castaneda and Joseph Jankovic; 12. VPA, lithium, amiodarone and other non-DA Michael Silver and Stewart A. Factor; 13. Anti-depressants and movement disorders Gilles Fénelon; 14. Ataxia Marina Sanchez Abraham and Oscar S. Gershanik; 15. Myoclonus and asterixis P. D. Thompson, T. J. Kleinig and T. E. Kimber; 16. Imaging in medication-induced Parkinsonism Danna Jennings; 17. Deep brain stimulation for Tardive disorders Bernardo Rodrigues and Kelvin L. Chou; Index.
About the author
Joseph H. Friedman is the Stanley Aronson Chair in Neurodegenerative Disorders at Butler Hospital, Professor of Neurology and Chief of the Division of Movement Disorders in the Department of Neurology at the Alpert Medical School of Brown University, Providence, RI, and Adjunct Professor in the School of Pharmacy at the University of Rhode Island, Kingston, RI, USA.
Summary
Covering various drugs including the major classes of medications working primarily on the brain, this all-encompassing review of medication-induced movement disorders aids early recognition and improved treatment. A vital reference for medical specialists and consultants in neurology, neuropharmacology and mental health, and clinicians prescribing medications crossing the blood-brain barrier.
